Rankings
▼
Calendar
AXSM
Axsome Therapeutics, Inc.
$8B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.31
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$656,192
Balance Sheet
Total Assets
$45M
Total Liabilities
$4M
Stockholders' Equity
$41M
Cash & Equivalents
$44M
← FY 2016
All Quarters
Q2 2016 →
AXSM Q1 2016 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
